The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). (Q35018563)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). |
scientific article |
Statements
1 reference
The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). (English)
1 reference
Bartosz Wasag
1 reference
Els Lierman
1 reference
Peter Meeus
1 reference
Jan Cools
1 reference
Peter Vandenberghe
1 reference
17 February 2011
1 reference
1 reference
Identifiers
1 reference